Novo Nordisk Ahead Of Plan To Deliver On $1.24 Billion Savings From Company Transformation, CFO Says
NVO•Company update on savings, Wegovy pricing and pill launch
Aug. 5 (Reuters) - Novo Nordisk A/S NOVOb.CO:
- Novo Nordisk expects to launch Wegovy pill in Germany in September
- Novo Nordisk CFO: We are ahead of plan to deliver on 8 billion DKK ($1.24 billion) savings from the company-wide transformation
- Novo Nordisk CEO: I don't measure our ambition by the number or the size of the acquisitions we make
- Novo Nordisk: Price dynamic for Wegovy injectable in the U.S. now is the same as what we started the year with
- Novo Nordisk: We are going to see quarter to quarter fluctuation in terms of the price-volume dynamics for Wegovy injectable in the U.S.
- Novo Nordisk CEO: We are increasingly surprised by how many people want the Wegovy pill compared to the injectable
Further company coverage: [NOVOb.CO]
($1 = 6.4700 Danish crowns)
